Login

CEO Fernando Lehner Discusses BVZ Holding AG's 2017 Annual Results: An Interview | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
XPON Technologies with Proactive at the ASX Small and Mid-Cap Conference | Matt Forman, CEO, XPON Technologies Group LtdXPN:ASX
00:10:00
Gem Diamonds: Transforming Production and Maximizing Value
00:10:00
Fiona Dawson on Embracing a Dynamic Mining Career and Promoting Diversity at Newmont
00:10:00
KlaraBo's Business Insights: CEO Andreas Morfiadakis Addresses Key Messages and Questions | Andreas Morfiadakis, CEO, KlaraBo Sverige AB.
00:00:00
Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd
00:10:00
Bigtincan CEO David Keane discusses strategies for promoting and reselling Bigtincan Hub to customers.
00:10:00
Setting Effective Financial Goals: From Resolutions to Results
00:10:00
CEO of the Year Kevin Ford on Techopia Live: Leadership Tips & Calian's Future | Kevin Ford - CEO of Calian Group Ltd.
00:10:00
Colombia's Miraflores Gold Project: Transformative Potential in Emerging Mining Landscape
00:10:00
Francesca Basso, journalist at Corriere della Sera, interviews Renato Mazzoncini, CEO & General Manager of A2A, on sustainability.
00:10:00
Transatlantic Gains: How Lucerne Fund Leveraged European Growth for Record Returns | Mark Whelan - Fund Manager, Lucerne Capital Management
00:10:00
Building Positive Financial Relationships: Insights from Richard Archer

© 2026 Nehu